{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:59:01Z","timestamp":1777611541411,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA043408"],"award-info":[{"award-number":["R01DA043408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA043408"],"award-info":[{"award-number":["R01DA043408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA043408"],"award-info":[{"award-number":["R01DA043408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA043408"],"award-info":[{"award-number":["R01DA043408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA043408"],"award-info":[{"award-number":["R01DA043408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Housing environments shape injection drug-related risks and harms and thus represent a critical implementation setting for syringe services programs (SSPs). As critical harm reduction measures, SSPs provide safe injecting equipment to people who inject drugs (PWID). Vancouver, Canada, has well-established syringe distribution programs through which PWID have low-threshold access to unlimited syringes and related injecting equipment, including through non-profit operated supportive housing and single-room occupancy hotels. This study examines the role of housing-based SSPs in distributing injecting equipment to PWID in Vancouver.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between January and March 2020, semi-structured, in-depth interviews were conducted in Vancouver with 26 PWID. Interviews were audio-recorded, transcribed, and coded. Salient themes were identified using inductive and deductive approaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Many participants accessed SSPs in housing facilities and expressed preference for these programs over those offered at other locations and through other health and social services. Three major themes emerged to explain this preference. First, most participants injected in the buildings where they resided, and housing-based SSPs made injecting equipment available when and where it was most needed. Second, many participants preferred to avoid carrying syringes outside of the places where they inject due to fears that syringe possession may lead to criminal charges or confiscation of syringes and\/or illicit drugs by police. Third, for some participants, anti-drug user stigma and concerns over unwillingly disclosing their drug use hindered access to SSPs outside of housing settings. Programs operated within housing facilities often offered greater client anonymity along with more supportive and less stigmatizing environments, particularly in the presence of peer staff.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The current study advances understanding of access to injecting equipment in a setting with city-wide syringe distribution programs. Our findings underscore the benefits of housing-based SSPs and encourage the expansion of such services to maximize access to harm reduction supports for PWID.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00862-2","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T07:02:21Z","timestamp":1694070141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study"],"prefix":"10.1186","volume":"20","author":[{"given":"Koharu Loulou","family":"Chayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly L.","family":"Sue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"862_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2005.09.002","volume":"17","author":"K Shannon","year":"2006","unstructured":"Shannon K, Ishida T, Lai C, Tyndall MW. The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver. Int J of Drug Policy. 2006;17:107\u201314.","journal-title":"Int J of Drug Policy"},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"SA Strathdee","year":"1997","unstructured":"Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59-65.","journal-title":"AIDS"},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2016.02.028","volume":"33","author":"D Ciccarone","year":"2016","unstructured":"Ciccarone D, Bourgois P. Injecting drugs in tight spaces: HIV, cocaine and collinearity in the downtown eastside, Vancouver, Canada. Int J Drug Policy. 2016;33:36\u201343.","journal-title":"Int J Drug Policy"},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11524-018-0294-y","volume":"96","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, Fleming T, Collins AB, Boyd J, McNeil R. Addressing intersecting housing and overdose crises in Vancouver, Canada: opportunities and challenges from a tenant-led overdose response intervention in single room occupancy hotels. J Urban Health. 2019;96:12\u201320.","journal-title":"J Urban Health"},{"key":"862_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107571","volume":"204","author":"CL Rowe","year":"2019","unstructured":"Rowe CL, Riley ED, Eagen K, Zevin B, Coffin PO. Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010\u20132017. Drug Alcohol Depend. 2019;204: 107571.","journal-title":"Drug Alcohol Depend"},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugpo.2005.02.004","volume":"16","author":"A Wodak","year":"2005","unstructured":"Wodak A, Cooney A. Effectiveness of sterile needle and syringe programmes. Int J Drug Policy. 2005;16:31\u201344.","journal-title":"Int J Drug Policy"},{"key":"862_CR7","unstructured":"WHO. People who inject drugs [Internet]. World Health Organization. 2023 [cited 2023 Mar 10]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/populations\/people-who-inject-drugs"},{"key":"862_CR8","unstructured":"UNAIDS. Health, rights and drugs\u2014Harm reduction, decriminalization and zero discrimination for people who use drugs [Internet]. 2019. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2954_UNAIDS_drugs_report_2019_en.pdf"},{"key":"862_CR9","unstructured":"WHO. Guide to starting and managing needle and syringe programmes. [Internet]. 2007. Available from: https:\/\/www.who.int\/hiv\/idu\/Guide_to_Starting_and_Managing_NSP.pdf"},{"key":"862_CR10","doi-asserted-by":"publisher","first-page":"109323","DOI":"10.1016\/j.drugalcdep.2022.109323","volume":"232","author":"CN Behrends","year":"2022","unstructured":"Behrends CN, Lu X, Corry GJ, LaKosky P, Prohaska SM, Glick SN, et al. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depend. 2022;232:109323.","journal-title":"Drug Alcohol Depend"},{"key":"862_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7517-4-14","volume":"4","author":"MM Islam","year":"2007","unstructured":"Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:14.","journal-title":"Harm Reduct J"},{"key":"862_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3109\/10826084.2011.521467","volume":"46","author":"SM Jenness","year":"2011","unstructured":"Jenness SM, Hagan H, Liu K-L, Wendel T, Murrill CS. Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing. Subst Use Misuse. 2011;46:192\u2013200.","journal-title":"Subst Use Misuse"},{"key":"862_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.17269\/s41997-018-0058-1","volume":"109","author":"AI Scheim","year":"2018","unstructured":"Scheim AI, Bardwell G, Rachlis B, Mitra S, Kerr T. Syringe sharing among people who inject drugs in London, Canada. Can J Public Health. 2018;109:174\u201382.","journal-title":"Can J Public Health"},{"key":"862_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/add.15151","volume":"116","author":"RH White","year":"2021","unstructured":"White RH, O\u2019Rourke A, Kilkenny ME, Schneider KE, Weir BW, Grieb SM, et al. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia. Addiction. 2021;116:328\u201336.","journal-title":"Addiction"},{"key":"862_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/phn.12823","author":"T Turner-Bicknell","year":"2021","unstructured":"Turner-Bicknell T. Implementing best-practice with a local syringe service program: needs-based syringe distribution. Public Health Nurs. 2021. https:\/\/doi.org\/10.1111\/phn.12823.","journal-title":"Public Health Nurs"},{"key":"862_CR16","unstructured":"Strike C, Miskovic M, Perri M, Xavier J, Edgar J, Buxton J, et al. Best practice recommendations for canadian programs that provide harm reduction supplies to people who use drugs and are at risk for HIV, HCV, and Other Harms: 2021. Toronto: Working Group on Best Practice for Harm Reduction Programs in Canada; 2021."},{"key":"862_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/00002030-200204120-00021","volume":"16","author":"E Wood","year":"2002","unstructured":"Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JSG, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16:941\u20133.","journal-title":"AIDS"},{"key":"862_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0955-3959(03)00132-4","volume":"15","author":"PM Spittal","year":"2004","unstructured":"Spittal PM, Small W, Wood E, Johnston C, Charette J, Lalibert\u00e9 N, et al. How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada. Int J Drug Policy. 2004;15:36\u201345.","journal-title":"Int J Drug Policy"},{"key":"862_CR19","first-page":"61","volume":"17","author":"T Kerr","year":"2006","unstructured":"Kerr T, Small W, Peeace W, Douglas D, Pierre A, Wood E. Harm reduction by a \u201cuser-run\u201d organization: a case study of the Vancouver Area Network of Drug Users (VANDU). IJDP. 2006;17:61\u20139.","journal-title":"IJDP"},{"key":"862_CR20","unstructured":"Javed Z, Burk K, Facente S, Pegram L, Ali A, Asher A. Syringe services programs: a technical package of effective strategies and approaches for planning, design, and implementation. Atlanta, GA: US Department of Health and Human Services, National Center for HIV\/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease, Control and Prevention; 2020."},{"key":"862_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.drugpo.2012.03.006","volume":"23","author":"E Hyshka","year":"2012","unstructured":"Hyshka E, Strathdee S, Wood E, Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 2012;23:261\u201370.","journal-title":"Int J Drug Policy"},{"key":"862_CR22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2105\/AJPH.2009.178467","volume":"100","author":"T Kerr","year":"2010","unstructured":"Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100:1449\u201353.","journal-title":"Am J Public Health"},{"key":"862_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.healthplace.2004.10.004","volume":"12","author":"T Corneil","year":"2006","unstructured":"Corneil T, Kuyper L, Shoveller J, Hogg R, Li K, Spittal P, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12:79\u201385.","journal-title":"Health Place"},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1258\/0956462971920497","volume":"8","author":"DM Patrick","year":"1997","unstructured":"Patrick DM, Strathdee SA, Archibald CP, Ofner M, Craib KJP, Cornelisse PGA, et al. Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437\u201345.","journal-title":"Int J STD AIDS"},{"key":"862_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-7-1","volume":"7","author":"D Small","year":"2010","unstructured":"Small D, Glickman A, Rigter G, Walter T. The Washington Needle Depot: fitting healthcare to injection drug users rather than injection drug users to healthcare: moving from a syringe exchange to syringe distribution model. Harm Reduct J. 2010;7:1.","journal-title":"Harm Reduct J"},{"key":"862_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.drugpo.2008.02.002","volume":"20","author":"B Tempalski","year":"2009","unstructured":"Tempalski B, McQuie H. Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy. 2009;20:4\u201313.","journal-title":"Int J Drug Policy"},{"key":"862_CR27","unstructured":"Vancouver Coastal Health. Housing overdose prevention site manual. [Internet]. 2018. Available from: http:\/\/www.vch.ca\/Documents\/Housing-overdose-revention-site-HOPS-Manual.pdf"},{"key":"862_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280:547.","journal-title":"JAMA"},{"key":"862_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1467-9671.2009.01182.x","volume":"14","author":"J-K Jung","year":"2010","unstructured":"Jung J-K, Elwood S. Extending the qualitative capabilities of GIS: computer-aided qualitative GIS. Trans GIS. 2010;14:63\u201387.","journal-title":"Trans GIS"},{"key":"862_CR30","volume-title":"Research design: qualitative, quantitative, and mixed methods approaches","author":"J Creswell","year":"2009","unstructured":"Creswell J. Research design: qualitative, quantitative, and mixed methods approaches. 3rd ed. Washington: Sage; 2009.","edition":"3"},{"key":"862_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13:85\u201394.","journal-title":"Int J Drug Policy"},{"key":"862_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.socscimed.2004.12.024","volume":"61","author":"T Rhodes","year":"2005","unstructured":"Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026\u201344.","journal-title":"Soc Sci Med"},{"key":"862_CR33","doi-asserted-by":"publisher","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523.","journal-title":"Soc Sci Med"},{"key":"862_CR34","unstructured":"Pivot Legal Society. Memorandum to the director of police services\u2019 street checks committee [Internet]. 2019. Available from: https:\/\/www.pivotlegal.org\/street_check_moratorium"},{"key":"862_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0955-3959(02)00008-7","volume":"13","author":"E Wood","year":"2002","unstructured":"Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, O\u2019Shaughnessy MV, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy. 2002;13:95\u2013102.","journal-title":"Int J Drug Policy"},{"key":"862_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11524-021-00534-1","volume":"98","author":"BT Hayes","year":"2021","unstructured":"Hayes BT, Favaro J, Davis CS, Gonsalves GS, Beletsky L, Vlahov D, et al. Harm reduction, by mail: the next step in promoting the health of people who use drugs. J Urban Health. 2021;98:532\u20137.","journal-title":"J Urban Health"},{"key":"862_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00042560-199509000-00016","volume":"10","author":"JP Grund","year":"1995","unstructured":"Grund JP, Heckathorn DD, Broadhead RS, Anthony DL. In eastern Connecticut, IDUs purchase syringes from pharmacies but don\u2019t carry syringes. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:104\u20135.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"862_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.drugpo.2019.08.002","volume":"73","author":"AB Collins","year":"2019","unstructured":"Collins AB, Boyd J, Mayer S, Fowler A, Kennedy MC, Bluthenthal RN, et al. Policing space in the overdose crisis: a rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites. Int J Drug Policy. 2019;73:199\u2013207.","journal-title":"Int J Drug Policy"},{"key":"862_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/01459740.1997.9966150","volume":"18","author":"RN Bluthenthal","year":"1997","unstructured":"Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1997;18:61\u201383.","journal-title":"Med Anthropol"},{"key":"862_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00126334-200309010-00019","volume":"34","author":"E Wood","year":"2003","unstructured":"Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. JAIDS J Acquir Immune Defic Syndr. 2003;34:116\u20137.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"862_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2105\/AJPH.2003.033563","volume":"95","author":"CS Davis","year":"2005","unstructured":"Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia. Pa Am J Public Health. 2005;95:233\u20136.","journal-title":"Pa Am J Public Health"},{"key":"862_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.drugalcdep.2014.09.778","volume":"144","author":"AV Rivera","year":"2014","unstructured":"Rivera AV, DeCuir J, Crawford ND, Amesty S, Lewis CF. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010\u20132012. Drug Alcohol Depend. 2014;144:259\u201364.","journal-title":"Drug Alcohol Depend"},{"key":"862_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/002204260403400201","volume":"34","author":"S Murphy","year":"2004","unstructured":"Murphy S, Kelley MS, Lune H. The health benefits of secondary syringe exchange. J Drug Issues. 2004;34:245\u201368.","journal-title":"J Drug Issues"},{"key":"862_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/00914509211035242","volume":"48","author":"K Gibson","year":"2021","unstructured":"Gibson K, Hutton F. Women who inject drugs (WWID): stigma, Gender and barriers to needle exchange programmes (NEPs). Contemp Drug Probl. 2021;48:276\u201396.","journal-title":"Contemp Drug Probl"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00862-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00862-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00862-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T13:37:48Z","timestamp":1700314668000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00862-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00862-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from University of British Columbia\/Providence Health Care Research Ethics Board. Consent to participate was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All data were de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}